RedShiftBio Homepage

Next Generation
in Protein
Characterization

RedShiftBio provides a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality.

Structure

Aggregation

Quantitation

Similarity

stability

Developing a New Carrier Protein for Conjugate Vaccines: Analytical Strategies for Similarity Testing and Formulation Development

Fina Biosolutions uses AQS³pro to demonstrate the biophysical and immunological comparability of protein conjugates used in vaccine development

Read the Pharmaceutical Outsoucing Article

AQS³®pro

The Next Generation in Protein Characterization

The AQS³pro brings protein secondary structure measurement into every stage of the biopharmaceutical pipeline. The AQS3pro generates repeatable, automated measurements with high sensitivity in complex formulation conditions that are not possible with traditional analytical methods.